Oxford–AstraZeneca COVID-19 vaccine efficacy

Saved in:
Bibliographic Details
Published inThe Lancet (British edition) Vol. 397; no. 10269; pp. 72 - 74
Main Authors Knoll, Maria Deloria, Wonodi, Chizoba
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 09.01.2021
Elsevier Limited
Subjects
Adverse events
Age
Asymptomatic
Brazil
Clinical trials
Comment
Coronaviruses
COVID-19
COVID-19 Vaccines
Disease transmission
Dosage
Freezers
Hemolytic anemia
Humans
Immunization
Immunogenicity
Immunology
Inflammatory diseases
Low temperature
mRNA
mRNA vaccines
Nursing homes
Older people
Regulatory approval
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
South Africa
Spinal cord
Supply chains
Temperature requirements
United Kingdom
Vaccine efficacy
Vaccines
Viral diseases
Viral Vaccines
Brazil
South Africa
United Kingdom
United Kingdom > UK
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Commentary-1
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(20)32623-4